Premium
CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR YOUNG PATIENTS WITH FIRST‐LINE FOLLICULAR LYMPHOMA: A POOLED ANALYSIS OF 4249 PATIENTS FROM THE FLASH DATABASE.
Author(s) -
Fornecker L.,
Ou F.,
Dixon J.G.,
Casulo C.,
Hoster E.,
Hiddemann W.,
Sebban C.,
Morschhauser F.,
Marcus R.,
Hochster H.,
Rummel M.,
Hagenbeeck A.,
Kimby E.,
Herold M.,
Peterson B.A.,
Gyan E.,
Ladetto M.,
Zucca E.,
Nielsen T.,
Foon K.,
Vitolo U.,
Flowers C.R.,
Shi Q.,
Salles G.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_89
Subject(s) - medicine , rituximab , follicular lymphoma , logistic regression , proportional hazards model , adverse effect , randomized controlled trial , stage (stratigraphy) , surgery , lymphoma , oncology , biology , paleontology